(A-I) BMAd-Pnpla2-/- male mice and littermate controls (Pnpla2+/+) were fed ad libitum until 24 weeks of age. Body weight (A), glucose tolerance test (B), and weights of subcutaneous WAT (sWAT), epididymal WAT (eWAT), and liver (C-E) were recorded. Decalcified tibiae were used for osmium tetroxide-staining and quantified by μCT analyses to measure the BMAT volume from proximal to distal ends, as indicated by boxed regions (F-G). Concentrations of glycerol and NEFA in serum (H) and bone marrow supernatant (I) were measured with colorimetric assay kits. Glycerol and NEFA contents in bone marrow supernatant were normalized to protein concentrations. (J-U) BMAd-Pnpla2-/- male mice and littermate controls (Pnpla2+/+) at 18 weeks of age and underwent a 30% CR for 6 weeks. Body weight changes (J) and glucose tolerance (K) were recorded. sWAT (L), eWAT (M), and liver (N) weights were measured during dissection. BMAT volume at different locations were quantified in osmium tetroxide-stained bones following μCT scanning (O-P). Representative images of proximal tibial rBMAT are shown (Q). Quantitative analyses of BMAd sizes were performed using MetaMorph software (R-S). Concentrations of glycerol and NEFA in serum (T) and bone marrow supernatant (U) were measured using colorimetric assays. Glycerol and NEFA contents in bone marrow supernatant were normalized to protein concentrations. (V) Immunoblot analyses of circulating adiponectin under non-reducing and non-heat-denaturing conditions (top panel), and denaturing conditions (middle panel), with albumin as a loading control (low panel). HMW: high molecular weight forms; MMW: medium molecular weight forms; LMW: low molecular weight. Data are expressed as mean ± SD. * indicates p<0.05 with a two-sample t-test.
Figure 3—figure supplement 1—source data 1. Blocking BMAd-lipolysis does not influence global metabolism when mice are fed ad libitum or calorically restricted.